Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Gregory Y. H. Lip, Cecile Laroche, Mircea Iaochim Popescu, Lars Hvilsted Rasmussen, Laura Vitali-Serdoz, Gheorghe-Andrei Dan, Zbigniew Kalarus, Harry J. G. M. Crijns, Mario Martins Oliveira, Luigi Tavazzi, Aldo P. Maggioni, Giuseppe Boriani

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1777-1786
JournalEP Europace
Volume17
Issue number12
DOIs
Publication statusPublished - Dec 2015

Keywords

  • Atrial fibrillation
  • Thromboembolism
  • Stroke
  • Mortality
  • Outcome
  • Anticoagulation
  • Guidelines

Cite this

Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G-A., Kalarus, Z., Crijns, H. J. G. M., Oliveira, M. M., Tavazzi, L., Maggioni, A. P., & Boriani, G. (2015). Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. EP Europace, 17(12), 1777-1786. https://doi.org/10.1093/europace/euv269